GlassScriptPhysician profile
Amalia D Pineres
NPI 1750449419
$971.86
in general payments reported to CMS, 2019-2025
21 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $92.31 · 2021: $47.25 · 2022: $12.06 · 2023: $140 · 2024: $168 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $152.38 | 2019-2024 | |
| Glaxosmithkline, LLC. | $108.87 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $90.76 | 2019-2024 | Breztri |
| Novartis Pharmaceuticals Corporation | $90.14 | 2019-2024 | |
| Allergan, INC. | $84.07 | 2019-2020 | |
| Abiomed | $71.42 | 2019 | |
| Lilly USA, LLC | $54.29 | 2020-2021 | |
| Ucb, INC. | $38.57 | 2025 | Zilbrysq |
| Abbvie INC. | $37.44 | 2019-2023 | |
| Medtronic, INC. | $28.58 | 2025 | Minimed 780g |
| Cycle Pharmaceuticals INC | $25.30 | 2025 | Tascenso Odt |
| Merck Sharp & Dohme LLC | $24.51 | 2019-2020 | |
| Novo Nordisk INC | $20.86 | 2021 | |
| Aimmune Therapeutics, INC. | $20.13 | 2025 | Zenpep |
| Astellas Pharma US INC | $20.03 | 2023 | Veozah |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.73 | 2019 | |
| Amgen INC. | $19.60 | 2025 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.03 | 2019 | |
| Exact Sciences Corporation | $17.52 | 2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $15.00 | 2023 | Quviviq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.63 | 2024-2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amalia Pineres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.